Brief: Isofol Medical Proposes No Dividend For 2022
Feb 22 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* Q4 NET REVENUE AMOUNTED TO TSEK 1,857 (4,704) AND OTHER
REVENUE
TO TSEK 57 (0)
* Q4 RESULT FOR PERIOD AMOUNTED TO TSEK -25,335 (-61,170)
* BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND WILL BE PAID
FOR
2022 FINANCIAL YEAR
Source text for Eikon: ID:nWkr7VslXZ
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism